Use of multiple international healthcare databases for the detection of rare drug-associated outcomes: a pharmacoepidemiological programme comparing rosuvastatin with other marketed statins-Reference-Cited by-同舟云学术

Use of multiple international healthcare databases for the detection of rare drug-associated outcomes: a pharmacoepidemiological programme comparing rosuvastatin with other marketed statins

Published:2010-10-04 Issue:12 Volume:19 Page:1218-1224
ISSN:1053-8569
Container-title:Pharmacoepidemiology and Drug Safety
language:en
Short-container-title:Pharmacoepidem. Drug Safe.

Author:

García Rodríguez Luis A.,Herings Ron,Johansson Saga

Publisher

Wiley

Subject

Pharmacology (medical),Epidemiology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/pds.2032/fullpdf

Reference26 articles.

1. The issue of statin safety: where do we stand?;Grundy;Circulation,2005

2. Incidence of hospitalized rhabdomyolysis in patients treated with lipid-lowering drugs;Graham;JAMA,2004

3. Safety of statins: focus on clinical pharmacokinetics and drug interactions;Bellosta;Circulation,2004

4. The myotoxicity of statins;Evans;Curr Opin Lipidol,2002

5. Statins and hepatotoxicity: focus on patients with fatty liver;Chalasani;Hepatology,2005

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association of Rosuvastatin Use with Risk of Hematuria and Proteinuria;Journal of the American Society of Nephrology;2022-09

2. Influence of statin‐potency on the risk of kidney disease – A nationwide cohort study using laboratory data;Pharmacoepidemiology and Drug Safety;2020-11-26

3. A Pharmacoepidemiology Database System for Monitoring Risk Due to the Use of Medicines by New Zealand Primary Care Patients;Drug Safety;2017-08-01

4. Statin‐induced liver injury in an area endemic for hepatitis B virus infection: risk factors and outcome analysis;British Journal of Clinical Pharmacology;2016-06-17

5. Effect of atorvastatin on the incidence of acute kidney injury following valvular heart surgery: a randomized, placebo-controlled trial;Intensive Care Medicine;2016-04-27